by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

R&D On Del Prado Inc, d/b/a Purple Rain DP Vape & Smoke Warning Letter Details

Warning Letter

R&D On Del Prado Inc, d/b/a Purple Rain DP Vape & Smoke

United States

Issue DateOctober 02, 2025

FEI NumberN/A

Violations3

CountryUnited States

Issuing Office

Center for Tobacco Products

Product Type

Tobacco

Status

Open

Summary

Based on limited metadata, R&D On Del Prado Inc, operating as Purple Rain DP Vape & Smoke, received an FDA Warning Letter on October 2, 2025, regarding tobacco products. The violations appear to involve issues with product adulteration and/or misbranding under the Family Smoking Prevention and Tobacco Control Act, though specific violation details are not available from the metadata provided. The FDA's Center for Tobacco Products issued this warning, indicating the agency's regulatory focus on the company's tobacco product compliance.

R&D On Del Prado Inc, d/b/a Purple Rain DP Vape & Smoke FDA Warning Letter, October 2, 2025